How much is Ensoma worth in 2026?

Ensoma has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Ensoma raised?

Ensoma has raised $258.0M in total funding across 3 funding rounds.

Ensoma

Drug DiscoveryWebsite

Ensoma valuation and funding history | Last updated: September 22, 2025 | 3 funding rounds

Current Valuation

N/A

As of September 22, 2025

Total Funding Raised

$258.0M

Across 3 rounds

Last Round

Later Stage VC

$53.0M

Last Funding

Sep 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 22, 2025	Later Stage VC (Series B1)	$53.0M	N/A	-
May 16, 2023	Early Stage VC (Series B)	$135.0M	N/A	-
February 19, 2021	Early Stage VC (Series A)	$70.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Ensoma is currently valued at N/A as of September 22, 2025. The company has raised a total of $258.0M in funding across 3 funding rounds.

Track Ensoma Valuation Updates

Get notified when Ensoma raises new funding or valuation changes

Explore More Data

Detailed analysis for Ensoma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Ensoma's valuation history, funding rounds, and growth metrics.

No credit card required

What is Ensoma Worth in 2026?

Ensoma is a leading private company in the Drug Discovery sector. Track Ensoma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Ensoma Valuation is Determined

Private company valuations like Ensoma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.